3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
59
Myelodysplastic Syndromes
51
Precursor Cell Lymphoblastic Leukemia-Lymphoma
49
Hodgkin Disease
49
Leukemia, Lymphocytic, Chronic, B-Cell
46
Leukemia
43
Multiple Myeloma
41
Lymphoma
41
Lymphoma, Non-Hodgkin
39
Lymphoma, Follicular
32
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
30
Lymphoma, Mantle-Cell
29
Lymphoma, Large B-Cell, Diffuse
29
Graft vs Host Disease
29
Myeloproliferative Disorders
28
Congenital Abnormalities
28
Lymphoma, B-Cell, Marginal Zone
27
Leukemia, Myeloid, Accelerated Phase
26
Leukemia, Myelomonocytic, Chronic
25
Hematologic Neoplasms
24
Burkitt Lymphoma
23
Primary Myelofibrosis
21
Neoplasms, Plasma Cell
20
Waldenstrom Macroglobulinemia
19
Leukemia, Myeloid, Chronic-Phase
19
Blast Crisis
19
Lymphoma, Large-Cell, Immunoblastic
17
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
15
Anemia, Refractory, with Excess of Blasts
15
Lymphoma, T-Cell, Cutaneous
14
Interventions
itepekimab
2
dupilumab
1
abrocitinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Dermatitis, Atopic
×
Tacrolimus
×
Clear all
No trials found.